# US 2026/0085304 A1 · Method of purifying and isolating collagenase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0085304 A1
- Document ID: US20260085304A1
- Status: Published application
- Kind: A1
- Application number: 19/336,963
- Filed: 2025-09-23
- Published: 2026-03-26
- Earliest claimed: 2017-03-28
- Assignees: Endo Operations Limited
- Applicants: Endo Operations Limited
- Inventors: Christine A. Sheaffer; Michael Berbaum; John Hanna; Jason Dziadosz; Daniel Shanafelt
- Web page: https://patentgrep.com/patent/US20260085304A1

## CPC

- C12N 9/52: derived from bacteria {or Archaea}
- C12Y 304/24003: Microbial collagenase (3.4.24.3)
- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- G01N 33/56911: {Bacteria}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to the fields of collagenase production and collagenase products, and particularly to improving the reproducibility, purity, and stability of collagenase I and collagenase II compositions, where the compositions are pure to at least 95% by area as measured by reverse phase high pressure liquid chromatography (RP-HPLC) and essentially free of neutral protease.

## Claims

### Claim 1

A composition comprising isolated and purified collagenase I and collagenase II, wherein the collagenase I and collagenase II are at least 95% pure by area as measured by reverse phase high pressure liquid chromatography (RP-HPLC), and
wherein the composition comprises less than 100 ng of neutral protease per mg of collagenase as measured by casein Zymography with or without densitometry, and
wherein the composition is made by a process comprising the step of separating a plurality of highly pure fractions of collagenase I or collagenase II from fractions of neutral protease.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the separating step comprises assaying fractions of the collagenase 1 and collagenase II and pooling only fractions of the collagenase that are free from detectable amounts of neutral protease.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the purified collagenase I and collagenase II is free from detectable amounts of neutral protease, as measured by casein Zymography with or without densitometry.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the process further comprises the step of fractionating a mixture of the collagenase I, collagenase II, and neutral protease using chromatography prior to the step of the step of separating the plurality of highly pure fractions of collagenase I or collagenase II from fractions of neutral protease.

### Claim 5 (depends on 4)

The composition of claim 4, wherein the chromatography comprises hydrophobic interaction chromatography, ion-exchange chromatography, or a combination thereof.

### Claim 6 (depends on 1)

The composition of claim 1, wherein prior to the step of separating a plurality of highly pure fractions of collagenase I or collagenase II from fractions of neutral protease the process further comprises the step of treating the collagenase I and collagenase II with a salt selected from ammonium sulfate, sodium chloride, potassium chloride, sodium sulfate, and mixtures thereof and forming a collagenase I and collagenase II solution,
wherein the salt comprises less than about 1.2 ppm of nickel and less than about 84.4 ppm of zinc.

### Claim 7 (depends on 6)

The composition of claim 6, wherein the salt comprises nickel in an amount of less than about 1.0 ppm, less than about 0.9 ppm, less than about 0.8 ppm, less than about 0.7 ppm, less than about 0.6 ppm, less than about 0.5 ppm, less than about 0.4 ppm, less than about 0.3 ppm, less than about 0.2 ppm, less than about 0.1 ppm, less than about 0.09 ppm, less than about 0.08 ppm, less than about 0.07 ppm, less than about 0.06 ppm, less than about 0.05 ppm, less than about 0.04 ppm, less than about 0.03 ppm, less than about 0.02 ppm, or less than about 0.01 ppm.

### Claim 8 (depends on 6)

The composition of claim 6, wherein the salt comprises zinc in an amount of less than about 80 ppm, less than about 50 ppm, less than about 25 ppm, less than about 10 ppm, less than about 5 ppm, less than about 3 ppm, or less than about 1 ppm.

### Claim 9 (depends on 6)

The composition of claim 6, wherein the salt further comprises low levels of metals selected from aluminum, arsenic, calcium, cadmium, chromium, copper, iron, magnesium, and lead.

### Claim 10 (depends on 6)

The composition of claim 6, wherein the salt comprises less than about 0.75 ppm aluminum, less than about 0.2 ppm arsenic, less than about 10 ppm calcium, less than about 1 ppm cadmium, less than about 0.75 ppm chromium, less than about 1 ppm copper, less than about 2 ppm iron, less than about 5 ppm magnesium, or less than about 2 ppm lead.

### Claim 11 (depends on 6)

The composition of claim 6, wherein the salt is ammonium sulfate.

### Claim 12 (depends on 11)

The composition of claim 11, wherein the ammonium sulfate has a concentration of about 0.8 M to about 1.2 M.
